Target intelligence / Profile preview

RNA, U6 small nuclear 102, pseudogene (RNU6-102P)

Target: RNU6-102P
Molecular classification: Other (Pseudogene)

Overview

RNU6-102P (RNA, U6 small nuclear 102, pseudogene) is a non-coding RNA gene classified as a pseudogene. It is similar in sequence to the functional U6 small nuclear RNA gene but is not believed to encode a functional RNA or protein product[1]. U6 snRNA itself plays an essential role in nuclear intron splicing as part of the spliceosome machinery[3][7], but pseudogenes such as RNU6-102P are generally regarded as non-functional remnants produced by genomic duplication or retrotransposition events[5]. While most pseudogenes do not produce functional products, some may be transcribed and may participate in regulatory RNA networks in specific cellular contexts[4][6]. There is no evidence that RNU6-102P itself is a therapeutic target, a receptor, or used as a biomarker, nor are there drugs directed at this molecule. If you need information on the functional U6 snRNA (rather than its pseudogenes), refer to U6 small nuclear RNA, which is a core component of the spliceosome and is essential for pre-mRNA splicing in eukaryotes[3][7].

Other names: RNU6-102PRNA, U6 small nuclear 102, pseudogene

Biological functions

Pseudogenes are generally non-functional at the protein level. However, emerging evidence suggests some pseudogene transcripts can act as regulatory RNAs (such as antisense RNAs, siRNAs, or competing endogenous RNAs) with potential regulatory roles[4][6].There is no evidence of specific biological functions for RNU6-102P.

Disease associations

There is no direct disease association reported for RNU6-102P.However, pseudogenes in general can have roles in cancer and gene regulation by acting as molecular sponges or through RNA interference mechanisms[4][6].

Beyond the preview

Go deeper on RNA, U6 small nuclear 102, pseudogene (RNU6-102P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 102, pseudogene (RNU6-102P).

Explore the full profile